AlloVir Inc [ALVR] stock prices are up 2.56% to $0.80 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The ALVR shares have gain 7.80% over the last week, with a monthly amount glided 6.67%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
AlloVir Inc [NASDAQ: ALVR] stock has seen the most recent analyst activity on December 26, 2023, when BofA Securities downgraded its rating to a Underperform and also revised its price target to $1 from $17. Previously, Piper Sandler downgraded its rating to Neutral on December 22, 2023. On December 22, 2023, downgrade downgraded it’s rating to Market Perform. JP Morgan downgraded its rating to a Underweight. BofA Securities initiated its recommendation with a Buy and recommended $17 as its price target on August 18, 2023. In a note dated August 24, 2020, SVB Leerink initiated an Outperform rating and provided a target price of $41 on this stock.
The stock price of AlloVir Inc [ALVR] has been fluctuating between $0.62 and $6.12 over the past year. AlloVir Inc [NASDAQ: ALVR] shares were valued at $0.80 at the most recent close of the market.
Analyzing the ALVR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.99, Equity is -0.99 and Total Capital is -1.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7752 points at the first support level, and at 0.7505 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8136, and for the 2nd resistance point, it is at 0.8273.
AlloVir Inc [ALVR] reported earnings per share of -$0.36 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.43/share, meaning a difference of $0.07 and a surprise factor of 16.30%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.39 per share as compared to estimates of -$0.42 per share, a difference of $0.03 representing a surprise of 7.10%.
Ratios To Look Out For
It’s worth pointing out that AlloVir Inc [NASDAQ:ALVR]’s Current Ratio is 6.61. On the other hand, the Quick Ratio is 6.61, and the Cash Ratio is 3.18.
Transactions by insiders
Recent insider trading involved Sinha Vikas,, that happened on Apr 22 ’24 when 1857.0 shares were sold. General Counsel, Miller Edward completed a deal on Apr 22 ’24 to sell 757.0 shares. Meanwhile, Chief Accounting Officer Hagen Brett R sold 480.0 shares on Apr 22 ’24.
